Home › Sleep Disorders › Alabama
Sleep Disorders clinical trials in Alabama
6 studies for Sleep Disorders are looking for participants at sites in Alabama.
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
- Cullman Clinical Trials, Cullman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07881757A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Cullman Clinical Trials, Cullman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07823608A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Birmingham, Alabama, Birmingham
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Nov 3, 2026 · NCT07598708A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Cullman
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Oct 9, 2026 · NCT06767683A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cullman
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Oct 7, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Cullman
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Oct 7, 2026 · NCT07502443From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.